Methyl 2-methyl-2H-indazole-3-carboxylate, 97%, 250mg

tert-Butyl 4-amino-4-[4-(trifluoromethyl)benzyl]piperidine-1-carboxylate, 1g

(2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide, 99+%, 250mg

PHTHALOYL DICHLORIDE, 95.0%, 500g

3,4-Epoxytetrahydrofuran>97.0%(GC)25g

METHYL 3-BROMO-4-FLUORO-1H-INDAZOLE-6-CARBOXYLATE, 95%, 100mg

D-Galactal, 95.0%, 25g

3-(Bromomethyl)phenyl acetate, 95.0%, 5g

Acide molybdophosphorique hydraté, min 99 %, pa, ACS, 25 g, emballage en verre

Système de vide série MZ 2 MZ 2C NT +AK+EK, 1 pièce

1-(3-ethoxyphenyl)ethanamine, 95.0%, 100mg

6-IODO-2-METHYL-2H-INDAZOLE, 95%, 10g

8-ethyl-4-(3-methylbenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g